Ritonavir Approved for Marketing Phase N/A Trials for Human Immunodeficiency Virus (HIV) Infections

IndicationsStatusPurposePhase
Approved for MarketingNot AvailableNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT00097799Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection